Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis

Adv Virus Res. 2021:109:201-254. doi: 10.1016/bs.aivir.2020.10.001. Epub 2020 Nov 9.

Abstract

The DNA viruses, Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are members of the gammaherpesvirus subfamily, a group of viruses whose infection is associated with multiple malignancies, including cancer. The primary host for these viruses is humans and, like all herpesviruses, infection with these pathogens is lifelong. Due to the persistence of gammaherpesvirus infection and the potential for cancer formation in infected individuals, there is a driving need to understand not only the biology of these viruses and how they remain undetected in host cells but also the mechanism(s) by which tumorigenesis occurs. One of the methods that has provided much insight into these processes is proteomics. Proteomics is the study of all the proteins that are encoded by a genome and allows for (i) identification of existing and novel proteins derived from a given genome, (ii) interrogation of protein-protein interactions within a system, and (iii) discovery of druggable targets for the treatment of malignancies. In this chapter, we explore how proteomics has contributed to our current understanding of gammaherpesvirus biology and their oncogenic processes, as well as the clinical applications of proteomics for the detection and treatment of gammaherpesvirus-associated cancers.

Keywords: EBV; Herpesvirus; KSHV; Oncogenic; Proteomics; Virus-host interactions.

Publication types

  • Review

MeSH terms

  • Books
  • Carcinogenesis*
  • DNA Viruses / pathogenicity
  • Gammaherpesvirinae / genetics
  • Gammaherpesvirinae / pathogenicity*
  • Herpesviridae Infections / complications
  • Herpesviridae Infections / drug therapy
  • Host Microbial Interactions*
  • Humans
  • Proteomics / methods*
  • Tumor Virus Infections / complications
  • Tumor Virus Infections / drug therapy
  • Virus Replication